Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Apple
AAPL
|
$564M |
| 2 |
UnitedHealth
UNH
|
$439M |
| 3 |
Johnson & Johnson
JNJ
|
$353M |
| 4 |
Amazon
AMZN
|
$200M |
| 5 |
Microsoft
MSFT
|
$198M |
Top Sells
| 1 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$344M |
| 2 |
JPMorgan Chase
JPM
|
$293M |
| 3 |
Kellanova
K
|
$165M |
| 4 |
SUM
Summit Materials, Inc. Class A Common Stock
SUM
|
$159M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
$156M |
Sector Composition
| 1 | Technology | 18.85% |
| 2 | Financials | 18.69% |
| 3 | Industrials | 11.95% |
| 4 | Healthcare | 10.42% |
| 5 | Consumer Discretionary | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3251
Actinium Pharmaceuticals
ATNM
$52.7M
| $56.2K | ﹤0.01% |
34,923
| – | – |
|
3252
Rapid Micro Biosystems
RPID
$108M
| $55.9K | ﹤0.01% |
+21,167
| New | +$55.9K |
|
|
SGMA
3253
DELISTED
Sigmatron International
SGMA
| $53.8K | ﹤0.01% |
43,052
-18,211
| -30% | -$22.8K |
|
3254
Ideal Power
IPWR
$43.3M
| $53.6K | ﹤0.01% |
+10,311
| New | +$53.6K |
|
3255
Sangamo Therapeutics
SGMO
$160M
| $52.8K | ﹤0.01% |
80,584
-3,686
| -4% | -$2.42K |
|
3256
Big 5 Sporting Goods
BGFV
$32.8M
| $52.8K | ﹤0.01% |
54,593
-64,787
| -54% | -$62.6K |
|
3257
Zynex
ZYXI
$45.1M
| $52.7K | ﹤0.01% |
23,932
+4,599
| +24% | +$10.1K |
|
|
ENZ
3258
DELISTED
Enzo Biochem, Inc.
ENZ
| $51.5K | ﹤0.01% |
138,126
-157,551
| -53% | -$58.7K |
|
3259
MEI Pharma
MEIP
$140M
| $51.3K | ﹤0.01% |
23,427
| – | – |
|
|
IMA
3260
ImageneBio, Inc. Common Stock
IMA
$94.5M
| $49.5K | ﹤0.01% |
3,218
| – | – |
|
|
IMAB
3261
I-MAB
IMAB
$355M
| $48.1K | ﹤0.01% |
58,358
| – | – |
|
3262
Acumen Pharmaceuticals
ABOS
$83.6M
| $47.9K | ﹤0.01% |
43,524
-54,492
| -56% | -$59.9K |
|
3263
Sono-Tek
SOTK
$57.6M
| $46.4K | ﹤0.01% |
12,737
| – | – |
|
3264
Aterian
ATER
$9.51M
| $45.7K | ﹤0.01% |
21,778
| – | – |
|
3265
VistaGen Therapeutics
VTGN
$111M
| $43.9K | ﹤0.01% |
+17,545
| New | +$43.9K |
|
3266
Assertio
ASRT
$77.7M
| $43.1K | ﹤0.01% |
63,833
-471
| -0.7% | -$318 |
|
3267
enVVeno Medical
NVNO
$15.2M
| $42.4K | ﹤0.01% |
16,119
-123
| -0.8% | -$323 |
|
3268
Butterfly Network
BFLY
$385M
| $41.9K | ﹤0.01% |
18,247
| – | – |
|
3269
Tenaya Therapeutics
TNYA
$202M
| $41.8K | ﹤0.01% |
73,408
-24,573
| -25% | -$14K |
|
3270
ImmunityBio
IBRX
$2.26B
| $40.1K | ﹤0.01% |
13,328
-14,638
| -52% | -$44.1K |
|
3271
Comstock
LODE
$124M
| $39.7K | ﹤0.01% |
+16,277
| New | +$39.7K |
|
3272
AlTi Global
ALTI
$432M
| $39.5K | ﹤0.01% |
12,985
+2,909
| +29% | +$8.84K |
|
3273
Blink Charging
BLNK
$117M
| $39.3K | ﹤0.01% |
42,819
-14,032
| -25% | -$12.9K |
|
3274
TechPrecision Corp
TPCS
$53.2M
| $39.2K | ﹤0.01% |
+17,026
| New | +$39.2K |
|
3275
Forian
FORA
$66.9M
| $36.3K | ﹤0.01% |
18,143
+2,551
| +16% | +$5.1K |
|